Notably, the present study revealed substantial upregulation of FKBP5 in residual high-grade serous ovarian cancer (HGSOC) tissues from patients undergoing neoadjuvant chemotherapy. Here, FKBP5 is linked to ovarian serous adenocarcinoma.